From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We?

Giacomo Tondo; Fabiola De Marchi

doi:10.3390/jcm11154515

From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We?

J Clin Med. 2022 Aug 3;11(15):4515. doi: 10.3390/jcm11154515.

Authors

Giacomo Tondo^{1

2}, Fabiola De Marchi³

Affiliations

¹ Neurology Unit, S. Andrea Hospital, Department of Translational Medicine, University of Piemonte Orientale, 13100 Vercelli, Italy.
² Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
³ ALS Centre, Neurology Unit, Maggiore della Carità Hospital, Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.

Abstract

The biomarkers era grew in the last two decades when several technical and methodological advances have improved the research in neurodegenerative diseases [...].

Publication types

Editorial

Grants and funding

This research received no external funding.